Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease

• Anna Machowska,

  Affiliation Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Jia Sun,

  Affiliation Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Abdul Rashid Qureshi,

  Affiliation Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Naohito Isoyama,

  Affiliations Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden, Department of Urology, Yamaguchi University, Ube, Yamaguchi, Japan

  ⨯
• Paul Leurs,

  Affiliations Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden, Admiraal de Ruyter Hospital, Goes, The Netherlands

  ⨯
• Björn Anderstam,

  Affiliation Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Olof Heimburger,

  Affiliation Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Peter Barany,

  Affiliation Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Peter Stenvinkel,

  Affiliation Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Bengt Lindholm

  * E-mail: Bengt.Lindholm@ki.se

  Affiliation Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden

  ⨯